Serum decorin is a potential prognostic biomarker in patients with acute exacerbation of idiopathic pulmonary fibrosis

about

Serum decorin is a potential prognostic biomarker in patients with acute exacerbation of idiopathic pulmonary fibrosis

Item

http://www.wikidata.org/entity/Q58770903

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Serum decorin is a potential p ...... idiopathic pulmonary fibrosis

@en

Serum decorin is a potential p ...... idiopathic pulmonary fibrosis

@nl

type

Item

label

Serum decorin is a potential p ...... idiopathic pulmonary fibrosis

@en

Serum decorin is a potential p ...... idiopathic pulmonary fibrosis

@nl

prefLabel

Serum decorin is a potential p ...... idiopathic pulmonary fibrosis

@en

Serum decorin is a potential p ...... idiopathic pulmonary fibrosis

@nl

P1476

Serum decorin is a potential p ...... idiopathic pulmonary fibrosis

@en

P2093

Atsuro Fukuhara

http://www.w3.org/2001/XMLSchema#string

Hiroshi Yokouchi

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Minemura

http://www.w3.org/2001/XMLSchema#string

Julia Morimoto

http://www.w3.org/2001/XMLSchema#string

Junpei Saito

http://www.w3.org/2001/XMLSchema#string

Kazue Saito

http://www.w3.org/2001/XMLSchema#string

Kenichi Misa

http://www.w3.org/2001/XMLSchema#string

Kenichiro Hirai

http://www.w3.org/2001/XMLSchema#string

Kenya Kanazawa

http://www.w3.org/2001/XMLSchema#string

Mami Rikimaru

http://www.w3.org/2001/XMLSchema#string

P2860

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

Pivotal role for decorin in angiogenesis

Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21

Negative regulation of transforming growth factor-beta by the proteoglycan decorin

An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis

Granzyme B cleaves decorin, biglycan and soluble betaglycan, releasing active transforming growth factor-β1

APACHE II: a severity of disease classification system

Baseline serum syndecan-4 predicts prognosis after the onset of acute exacerbation of idiopathic interstitial pneumonia

P304

5346-5358

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/JTD.2018.08.60

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30416782

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis

biomarker

P932

6196213

http://www.w3.org/2001/XMLSchema#string